Table 1 Study Participant Characteristics
From: Alveolar macrophages from EVALI patients and e-cigarette users: a story of shifting phenotype
| Â | Healthy | E-Cig | EVALI |
|---|---|---|---|
Number | 7 | 13 | 10 |
Age (median) | 28 | 23 | 22 |
Reported Sex | Â | Â | Â |
 Female (%) | 2 (29) | 7 (54) | 5 (50) |
 Male (%) | 5 (71) | 6 (46) | 5 (50) |
Race | Â | Â | Â |
 Caucasian (%) | 3 (43) | 9 (69) | 8 (80) |
 American Indian or Alaskan Native (%) | 0 (0) | 0 (0) | 1 (10) |
 Native Hawaiian or Other Pacific Islander (%) | 0 (0) | 1 (8) | 0 (0) |
 Other (%) | 0 (0) | 1 (8) | 0 (0) |
 Undisclosed/Refused (%) | 4 (57) | 2 (15) | 1 (10) |
Ethnicity | Â | Â | Â |
 Non-Hispanic (%) | 3 (43) | 10 (77) | 7 (70) |
 Hispanic (%) | 0 (0) | 1 (8) | 2 (20) |
 Undisclosed/Refused (%) | 4 (57) | 2 (15) | 1 (10) |
Years Vaped (median) | n/a | 3 | 2.5 |
Product Vaped | Â | Â | Â |
 Nicotine (%) | n/a | 11 (85) | 6 (60) |
 THC/CBD (%) | n/a | 4 (31) | 10 (100) |
 Dual-Use (%) | n/a | 2 (15) | 6 (60)* |
Number Puffs Per Day | Â | Â | Â |
 <10 Puffs Per Day (%) | n/a | 5 (50)** | 2 (20) |
 >10 Puffs Per Day (%) | n/a | 5 (50)** | 8 (80) |